[1] Pruinelli
L, Westra BL, Yadav P, et al. Delay within the 3-hour surviving sepsis campaign
guideline on mortality for patients with severe sepsis and septic shock[J].
Crit Care Med, 2018, 46(4):500-505. DOI: 10.1097/CCM.0000000000002949.
[2] 郭锦均,李琳红,梁木华,等.降钙素原和超敏C反应蛋白与乳酸检测在儿童脓毒症中的临床价值[J].国际医药卫生导报,2021,27(3):359-361. DOI:10.3760/cma.j.issn.1007- 1245.2021.03.013.
[3] 王青.血乳酸、降钙素原和肌钙蛋白I联合检测对脓毒症临床预后的评估价值[J].山东医药,2019,59(8):67-69. DOI:10.3969/j.issn.1002-266X.2019.08.019.
[4] Jiang W, Yu X, Sun T, et al. ADJunctive
Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a
randomized controlled trial[J]. Trials, 2018, 19(1):133. DOI:
10.1186/s13063-018-2513-y.
[5] 赵梦雅,段美丽.血乳酸和乳酸清除率与降钙素原联合检测对脓毒症患者病情严重程度及预后评估的临床意义[J].中华危重病急救医学,2020,32(4):449-453. DOI:10.3760/cma.j.cn121430-20200129-00086.
[6] Serafim R, Gomes JA, Salluh J, et al. A
comparison of the quick-SOFA and systemic inflammatory response syndrome
criteria for the diagnosis of sepsis and prediction of mortality: a systematic
review and meta-analysis[J]. Chest, 2018, 153(3):646-655. DOI:
10.1016/j.chest.2017.12.015.
[7] 周巧,马渝,肖玲,等.脓毒症患者血清miRNA-21和PCT动态表达及其临床意义[J].重庆医科大学学报,2018,43(7):907-912.
DOI:10.13406/j.cnki.cyxb.001519.
[8] 石苗,王超.血清可溶性白细胞分化抗原14亚型检测在脓毒症的临床应用价值研究进展[J].军事医学,2020,44(1):77-80.
DOI:10.7644/j.issn.1674-9960.2020.01.015.
[9] Goulden R, Hoyle MC, Monis J, et al.
qSOFA, SIRS and NEWS for predicting inhospital mortality and ICU admission in
emergency admissions treated as sepsis[J]. Emerg Med J, 2018, 35(6):345-349.
DOI: 10.1136/emermed-2017-207120.
[10] 石晓娜,徐梅先,霍习敏,等.脓毒症患儿早期血清白介素1受体1和活性蛋白C及降钙素原表达水平及其临床意义研究[J].中国全科医学,2018,21(20):2459-2462.
DOI:10.3969/j.issn.1007-9572.2018.00.035.
[11] 杨惠聪,吴阿阳,林洁,等.降钙素原、D-二聚体结合快速序贯器官功能衰竭评估评分在脓毒症诊疗中的应用[J].中国感染与化疗杂志,2020,20(5):498-501. DOI:10.16718/j.1009-7708.2020.05.008.
[12] 张芳晓,章志丹,马晓春.中性粒细胞胞外诱捕网与脓毒症凝血功能障碍的研究进展[J].中华危重病急救医学,2017,29(8):752-755.
DOI:10.3760/cma.j.issn.2095-4352. 2017.08.017.
[13] 孟强,屈峰,董伟,等.外周血游离DNA/NETs在脓毒症诊断和预后评估中的应用价值[J].中国呼吸与危重监护杂志,2018,17(3):255-258. DOI:10.7507/1671-6205. 201706035.
[14] 汪雯心,万敬员,唐艺.中性粒细胞胞外诱捕网在脓毒症中的研究进展[J].生命科学,2019,31(2):185-189. DOI:10.13376/j.cbls/2019027.
[15] 胡琼源.中性粒细胞胞外诱捕网在脓毒症及肠屏障功能中的研究进展[J].医学研究生学报,2019,32(10):1084-1088.
DOI:10.16571/j.cnki.1008-8199.2019.10.015.
[16] 曹维嘉,邵子玮,段孟洮,等.中性粒细胞胞外诱捕网(NETs)及其在相关炎性疾病的研究进展[J].中国免疫学杂志,2019,35(5):635-638. DOI:10.3969/j.issn.1000- 484X.2019.05.025.
[17] Gavillet M, Martinod K, Renella R, et
al. A key role for Rac and Pak signaling in neutrophil extracellular traps
(NETs) formation defines a new potential therapeutic target[J]. Am J Hematol,
2018, 93(2):269-276. DOI: 10.1002/ajh.24970.
[18] 董照刚,郑喜胜,贾明雅,等.抗菌药物降阶梯治疗对脓毒症患者外周血NETs及T淋巴细胞水平的影响[J].中华医院感染学杂志,2020,30(22):3409-3413. DOI:10.11816/cn.ni.2020-200325.
|